FIELD: medicine, phthisiology. SUBSTANCE: cycloserine at 15 mcg/ml concentration is added into chambers with murine pulmonary tissue culture infected by tubercular mycobacteria resistant to rifampicin and ethamebutol used at concentrations of 1-2 mcg/ml. EFFECT: decreased resistance of tubercular mycobacteria. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING MEDICINE-RESISTANT TUBERCULOSIS | 2001 |
|
RU2197965C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
METHOD FOR TREATING BACILLARY FORM OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2240806C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
METHOD FOR TREATING DESTRUCTIVE PULMONARY TUBERCULOSIS | 1989 |
|
RU2033159C1 |
METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
Authors
Dates
2002-07-20—Published
1999-10-28—Filed